[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Longeveron Inc (LGVN)

Longeveron Inc (LGVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Longeveron Inc 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 USA

https://longeveron.com Employees: 38 P: 305-909-0840

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.

Key Statistics

Overview:

Market Capitalization, $K 19,666
Enterprise Value, $K 15,176
Shares Outstanding, K 23,268
Float, K 20,662
% Float 88.80%
Short Interest, K 2,904
Short Float 12.48%
Days to Cover 2.71
Short Volume Ratio 0.40
% of Insider Shareholders 11.20%
% of Institutional Shareholders 10.01%

Financials:

Annual Sales, $ 1,200 K
Annual Net Income, $ -22,700 K
Last Quarter Sales, $ 370 K
Last Quarter Net Income, $ -5,440 K
EBIT, $ -23,290 K
EBITDA, $ -22,060 K

Growth:

1-Year Return -43.28%
3-Year Return -97.44%
5-Year Return -98.41%
5-Year Revenue Growth -78.69%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 03/17/26
Next Earnings Date 05/13/26 [AMC]
Earnings Per Share ttm -1.28
EPS Growth vs. Prev Qtr 43.59%
EPS Growth vs. Prev Year -68.43%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 03/27/24

LGVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -199.79%
Return-on-Assets % -143.21%
Profit Margin % -1,891.67%
Debt/Equity 0.03
Price/Sales 16.53
Price/Cash Flow N/A
Price/Book 3.44
Book Value/Share 0.25
Interest Coverage -0.88
60-Month Beta -0.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.